These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 15798098)

  • 1. Noncalcemic actions of vitamin D receptor ligands.
    Nagpal S; Na S; Rathnachalam R
    Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor as a drug discovery target.
    Pinette KV; Yee YK; Amegadzie BY; Nagpal S
    Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D analogs: mechanism of action and therapeutic applications.
    Nagpal S; Lu J; Boehm MF
    Curr Med Chem; 2001 Nov; 8(13):1661-79. PubMed ID: 11562285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of stereochemistry on the actions of vitamin D.
    Chiellini G; DeLuca HF
    Curr Top Med Chem; 2011; 11(7):840-59. PubMed ID: 21291397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
    Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
    J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor modulators for inflammation and cancer.
    Yee YK; Chintalacharuvu SR; Lu J; Nagpal S
    Mini Rev Med Chem; 2005 Aug; 5(8):761-78. PubMed ID: 16101412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.
    Adorini L
    Int Immunopharmacol; 2002 Jun; 2(7):1017-28. PubMed ID: 12188026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D endocrine system and psoriasis vulgaris--review of the literature.
    Rucević I; Barisić-Drusko V; Glavas-Obrovac L; Stefanić M
    Acta Dermatovenerol Croat; 2009; 17(3):187-92. PubMed ID: 19818218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
    Birlea SA; Costin GE; Norris DA
    Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
    Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress of study on vitamin D analogs].
    Kittaka A; Saito N; Takano M
    Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
    Makishima M
    Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of autoimmune diseases by the vitamin D endocrine system.
    Adorini L; Penna G
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):404-12. PubMed ID: 18594491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.